VR-RELIEF PCP - Phases 1 - 3
Chronic pain is associated with many different diagnostic entities ranging from diseases and other muscular-skeletal conditions to neuropathic pain conditions.
EU CEC-H2020 VIA RELIEF PCP (GIP RESAH)
£5,123.00 + £31,937.00 + £11,554.00
About the Project
Chronic pain is associated with many different diagnostic entities ranging from diseases like e.g. osteoarthritis, low-back pain and other muscular-skeletal conditions to neuropathic pain conditions like painful diabetic polyneuropathy and pain following a stroke or multiple sclerosis.
Due to this, treatment also varies from patient to patient and may include pharmacological treatments, neuromodulation, physiotherapy, multimodal rehabilitation.
Chronic pain may, in many instances, be a complex syndrome of pain, disability, fatigue and often further complicated by psycho-social impact. Due to the high prevalence and the bio-psycho-social impact of having chronic pain, the cost to society is high.
Projected key outcomes
- Improvement on the knowledge of the patient base data before first visit (Efficiency)
- Improvement on following-up (monitor) with the patient and the treatment (Pharmacological and non-pharmacological aspects)
- Increase the effectiveness of adherence to treatment
- Increase self-management and self-empowerment of the pain: integrate the patient with their healthcare